Lista de obras - Kizzmekia Corbett - Dominio Público Uruguay

A high-throughput inhibition assay to study MERS-CoV antibody interactions using image cytometry

scientific article published on 20 November 2018

A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone

artículo científico publicado en 2020

An mRNA Vaccine against SARS-CoV-2 - Preliminary Report

artículo científico publicado en 2020

Burden of dengue infection and disease in a pediatric cohort in urban Sri Lanka

artículo científico publicado en 2014

Characterization of Human Antibody Responses to Dengue Virus Infections in a Sri Lankan Pediatric Cohort

Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation

artículo científico publicado en 2020

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

scientific article published on 19 February 2020 in Science

Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies

scientific article published on 05 December 2018

Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages

artículo científico publicado en 2019

Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants

artículo científico publicado en 2021

Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants

artículo científico publicado en 2021

Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates

artículo científico publicado en 2020

Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses

artículo científico publicado en 2020

Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates

artículo científico publicado en 2021

Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen.

artículo científico publicado en 2017

Importance of neutralizing monoclonal antibodies targeting multiple antigenic sites on MERS-CoV Spike to avoid neutralization escape

artículo científico publicado en 2018

LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection

artículo científico publicado en 2020

Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination

artículo científico publicado en 2010

Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses

artículo científico publicado en 2021

Pre-fusion structure of a human coronavirus spike protein.

artículo científico publicado en 2016

Preexisting neutralizing antibody responses distinguish clinically inapparent and apparent dengue virus infections in a Sri Lankan pediatric cohort

artículo científico publicado en 2014

Primary Human mDC1, mDC2, and pDC Dendritic Cells Are Differentially Infected and Activated by Respiratory Syncytial Virus ⬇️

artículo científico publicado el 28 de enero de 2011

Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates

Prototype pathogen approach for pandemic preparedness: world on fire

scientific article published on 30 April 2020

Publisher Correction: Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis

artículo científico publicado en 2018

Receptor binding and proteolysis do not induce large conformational changes in the SARS-CoV spike

artículo científico publicado en 2018

SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness

artículo científico publicado en 2020

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

artículo científico publicado en 2020

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

artículo científico publicado en 2020

Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal Betacoronaviruses

artículo científico publicado en 2020

Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine

artículo científico publicado en 2021

Severe Acute Respiratory Syndrome Coronavirus 2 Prevalence, Seroprevalence, and Exposure Among Evacuees from Wuhan, China, 2020

artículo científico publicado en 2020

Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis

artículo científico publicado en 2018

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies

artículo científico publicado en 2020

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies

artículo científico publicado en 2020

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-domain Camelid Antibodies

artículo científico publicado en 2020

Structural Definition of a Neutralization-Sensitive Epitope on the MERS-CoV S1-NTD

artículo científico publicado en 2019

Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes

artículo científico publicado en 2020

Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes

artículo científico publicado en 2020

Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes ⬇️

artículo científico publicado en 2020

The duty to mentor, be visible and represent

artículo científico publicado en 2020

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

artículo científico publicado en 2021

Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedles

artículo científico publicado en 2015

Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and sero-surveillance

artículo científico publicado en 2020

mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates

scholarly article by Kizzmekia Corbett et al published 20 August 2021 in Nature Immunology

mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants

artículo científico publicado en 2021

Lista de obras de Kizzmekia Corbett

A high-throughput inhibition assay to study MERS-CoV antibody interactions using image cytometry

A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone

An mRNA Vaccine against SARS-CoV-2 - Preliminary Report

Burden of dengue infection and disease in a pediatric cohort in urban Sri Lanka

Characterization of Human Antibody Responses to Dengue Virus Infections in a Sri Lankan Pediatric Cohort

Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies

Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages

Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants

Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants

Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates

Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses

Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates

Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen.

Importance of neutralizing monoclonal antibodies targeting multiple antigenic sites on MERS-CoV Spike to avoid neutralization escape

LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection

Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination

Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses

Pre-fusion structure of a human coronavirus spike protein.

Preexisting neutralizing antibody responses distinguish clinically inapparent and apparent dengue virus infections in a Sri Lankan pediatric cohort

Primary Human mDC1, mDC2, and pDC Dendritic Cells Are Differentially Infected and Activated by Respiratory Syncytial Virus ⬇️

Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates

Prototype pathogen approach for pandemic preparedness: world on fire

Publisher Correction: Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis

Receptor binding and proteolysis do not induce large conformational changes in the SARS-CoV spike

SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal Betacoronaviruses

Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine

Severe Acute Respiratory Syndrome Coronavirus 2 Prevalence, Seroprevalence, and Exposure Among Evacuees from Wuhan, China, 2020

Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-domain Camelid Antibodies

Structural Definition of a Neutralization-Sensitive Epitope on the MERS-CoV S1-NTD

Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes

Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes

Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes ⬇️

The duty to mentor, be visible and represent

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedles

Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and sero-surveillance

mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates

mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants